Literature DB >> 18023394

A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice.

Muhammad T Imtiaz1, John T Distelhorst, Justin H Schripsema, Ira M Sigar, John N Kasimos, Shanon R Lacy, Kyle H Ramsey.   

Abstract

Matrix metalloproteinases (MMPs) are a family of host-derived enzymes involved in the turnover of extracellular matrix (ECM) molecules and the processing of cytokines, chemokines and growth factors. We have previously reported that global inhibition of MMP in Chlamydia muridarum urogenital tract infection of susceptible strains of female mice impeded ascension of C. muridarum into the upper genital tract, blunted acute inflammatory responses and reduced the rate of formation of chronic disease. Because we have also observed that MMP-9 (also known as gelatinase B) is expressed in relatively large quantities in susceptible strains of mice in response to infection during acute phases of infection, we explored this further in a more selected fashion. We infected MMP-9 gene knockout mice and wild type controls intravaginally with C. muridarum. Both groups of mice had similar isolation rates from the lower urogenital tract but the absence of MMP-9 resulted in a slightly lower isolation rate in the upper genital tract, blunted acute inflammatory indices in the affected tissues and a reduced rate of formation of hydrosalpinx-a surrogate marker of infertility. These results imply that MMP-9 is involved in pathogenesis of chlamydial infection in this model possibly by amplifying inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023394      PMCID: PMC2180419          DOI: 10.1016/j.micinf.2007.08.010

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  27 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 2.  Proteolysis and cell migration: creating a path?

Authors:  G Murphy; J Gavrilovic
Journal:  Curr Opin Cell Biol       Date:  1999-10       Impact factor: 8.382

Review 3.  Matrix metalloproteinases as modulators of inflammation and innate immunity.

Authors:  William C Parks; Carole L Wilson; Yolanda S López-Boado
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

4.  Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.

Authors:  T Darville; C W Andrews; K K Laffoon; W Shymasani; L R Kishen; R G Rank
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice.

Authors:  T W Cotter; K H Ramsey; G S Miranpuri; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.

Authors:  K H Ramsey; T W Cotter; R D Salyer; G S Miranpuri; M A Yanez; C E Poulsen; J L DeWolfe; G I Byrne
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

7.  Infertility as a consequence of chlamydial infection of the upper genital tract in female mice.

Authors:  C E Swenson; J Schachter
Journal:  Sex Transm Dis       Date:  1984 Apr-Jun       Impact factor: 2.830

8.  Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility.

Authors:  L M de la Maza; S Pal; A Khamesipour; E M Peterson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis.

Authors:  A L Barron; H J White; R G Rank; B L Soloff; E B Moses
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

10.  Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.

Authors:  H Su; R Messer; W Whitmire; E Fischer; J C Portis; H D Caldwell
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

View more
  28 in total

Review 1.  Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.

Authors:  Hossam Abdelsamed; Jan Peters; Gerald I Byrne
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

2.  Molecular Pathogenesis of Chlamydia Disease Complications: Epithelial-Mesenchymal Transition and Fibrosis.

Authors:  Joseph U Igietseme; Yusuf Omosun; Tamas Nagy; Olga Stuchlik; Matthew S Reed; Qing He; James Partin; Kahaliah Joseph; Debra Ellerson; Zenas George; Jason Goldstein; Francis O Eko; Claudiu Bandea; Jan Pohl; Carolyn M Black
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

3.  Caspase-11 Contributes to Oviduct Pathology during Genital Chlamydia Infection in Mice.

Authors:  Clare E Gyorke; Manoj K Tripathy; John Allen; Yugen Zhang; Angela Lovett; Stephanie A Montgomery; Uma M Nagarajan
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

4.  Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during Chlamydia muridarum infection.

Authors:  Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Matthew A Zurenski; Toni Darville
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

5.  Murine MicroRNA-214 regulates intracellular adhesion molecule (ICAM1) gene expression in genital Chlamydia muridarum infection.

Authors:  Tanvi Arkatkar; Rishein Gupta; Weidang Li; Jieh-Juen Yu; Shradha Wali; M Neal Guentzel; James P Chambers; Lane K Christenson; Bernard P Arulanandam
Journal:  Immunology       Date:  2015-06-29       Impact factor: 7.397

6.  Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.

Authors:  Srikanth Manam; Joshua D Thomas; Weidang Li; Allison Maladore; Justin H Schripsema; Kyle H Ramsey; Ashlesh K Murthy
Journal:  J Infect Dis       Date:  2014-12-30       Impact factor: 5.226

7.  Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model.

Authors:  Uma M Nagarajan; Daniel Prantner; James D Sikes; Charles W Andrews; Anna M Goodwin; Shanmugam Nagarajan; Toni Darville
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

8.  IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis.

Authors:  Lauren C Frazer; Amy M Scurlock; Matthew A Zurenski; Melissa M Riley; Margaret Mintus; Derek A Pociask; Jeanne E Sullivan; Charles W Andrews; Toni Darville
Journal:  Am J Reprod Immunol       Date:  2013-12       Impact factor: 3.886

9.  Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi.

Authors:  Andrew J Heilpern; Warren Wertheim; Jia He; George Perides; Roderick T Bronson; Linden T Hu
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

10.  Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.

Authors:  Rishein Gupta; Harsh Vardhan; Pragya Srivastava; Sudha Salhan; Aruna Mittal
Journal:  Reprod Biol Endocrinol       Date:  2009-08-22       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.